Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BOLT CVE:CZX CVE:TLG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBOLTBolt Biotherapeutics$3.99$4.77$3.91▼$7.20$7.67M1.1228,510 shs68,062 shsCZXCanada Zinc MetalsC$0.31+∞C$0.31C$0.22▼C$0.39C$51.69MN/A238,645 shs118,500 shsTLGTroilus GoldC$0.83+18.6%C$0.83C$0.70▼C$2.25C$40.45MN/A23,745 shs852 shsThe 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBOLTBolt Biotherapeutics0.00%-12.50%-13.45%-16.18%-29.51%CZXCanada Zinc Metals0.00%0.00%0.00%0.00%0.00%TLGTroilus Gold0.00%0.00%0.00%0.00%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBOLTBolt Biotherapeutics$3.99$4.77$3.91▼$7.20$7.67M1.1228,510 shs68,062 shsCZXCanada Zinc MetalsC$0.31+∞C$0.31C$0.22▼C$0.39C$51.69MN/A238,645 shs118,500 shsTLGTroilus GoldC$0.83+18.6%C$0.83C$0.70▼C$2.25C$40.45MN/A23,745 shs852 shsThe 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBOLTBolt Biotherapeutics0.00%-12.50%-13.45%-16.18%-29.51%CZXCanada Zinc Metals0.00%0.00%0.00%0.00%0.00%TLGTroilus Gold0.00%0.00%0.00%0.00%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBOLTBolt Biotherapeutics 2.40Hold$34.67768.84% UpsideCZXCanada Zinc Metals 0.00N/AN/AN/ATLGTroilus Gold 3.00BuyC$3.00261.45% UpsideCurrent Analyst Ratings BreakdownLatest TLG, BOLT, and CZX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/28/2026BOLTBolt Biotherapeutics Rodman & RenshawSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$22.005/28/2026BOLTBolt Biotherapeutics HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$7.004/20/2026BOLTBolt Biotherapeutics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/6/2026TLGTroilus Gold Ventum FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuyC$4.00(Data available from 6/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBOLTBolt Biotherapeutics$7.70M0.99N/AN/A$13.81 per share0.29CZXCanada Zinc MetalsN/AN/AN/AN/AN/AN/ATLGTroilus GoldN/AN/AC$0.41 per share2.05C$0.35 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBOLTBolt Biotherapeutics-$33.38M-$16.33N/AN/AN/A-455.15%-100.89%-48.23%8/13/2026 (Estimated)CZXCanada Zinc MetalsN/AN/AN/AN/AN/AN/AN/AN/AN/ATLGTroilus GoldN/A-C$0.91N/AN/AN/AN/AN/AN/AN/ALatest TLG, BOLT, and CZX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2026Q1 2026BOLTBolt Biotherapeutics-$2.85-$4.31-$1.46-$4.31$1.50 million$0.03 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBOLTBolt BiotherapeuticsN/AN/AN/AN/AN/ACZXCanada Zinc MetalsN/AN/AN/AN/AN/ATLGTroilus GoldN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBOLTBolt Biotherapeutics0.983.513.51CZXCanada Zinc MetalsN/AN/AN/ATLGTroilus Gold2.237.437.28Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBOLTBolt Biotherapeutics86.70%CZXCanada Zinc MetalsN/ATLGTroilus GoldN/AInsider OwnershipCompanyInsider OwnershipBOLTBolt Biotherapeutics9.40%CZXCanada Zinc MetalsN/ATLGTroilus GoldN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBOLTBolt Biotherapeutics901.92 million1.74 millionNot OptionableCZXCanada Zinc Metals147,000166.73 millionN/ANot OptionableTLGTroilus GoldN/A48.74 millionN/ANot OptionableTLG, BOLT, and CZX HeadlinesRecent News About These CompaniesTroilus drills shallow gold, boosts Quebec satellite caseJune 12, 2026 | northernminer.comNTroilus Secures Second Major Offtake Partner for Quebec Copper ProjectMarch 17, 2026 | thedeepdive.caTTroilus locks in European smelter support as project financing progressesMarch 17, 2026 | canadianminingjournal.comCTroilus Signs Memorandum of Understanding With Boliden for Long‑Term Copper‑Gold Concentrate OfftakeMarch 17, 2026 | financialpost.comFDelta Resources Announces Closing of the Delta-2 Option with Troilus Mining Delivering up to $8.25M Non-Dilutive Funding and 1% NSR RoyaltyFebruary 17, 2026 | juniorminingnetwork.comTroilus Mining Corp.February 13, 2026 | barrons.comJV Video: Troilus targets spring finance decisionFebruary 10, 2026 | canadianminingjournal.comCTroilus Mining Marks Breakthrough Year as Flagship Copper-Gold Project Moves Toward ConstructionJanuary 30, 2026 | theglobeandmail.comTroilus Mining Corp.: Troilus Provides Overview of Its 2025 Exploration Program and Initial Results Confirming Mineral Resource Upside Near Pit and Across PropertyJanuary 22, 2026 | finanznachrichten.deTroilus Provides Overview of Its 2025 Exploration Program and Initial Results Confirming Mineral Resource Upside Near Pit and Across PropertyJanuary 22, 2026 | markets.businessinsider.comTroilus Gold completes name change to Troilus MiningDecember 5, 2025 | msn.comTroilus Gold Corp. Upsizes Debt Financing to $1 Billion for Troilus ProjectNovember 19, 2025 | tipranks.comTroilus Gold Corp. Secures $172.5 Million in Public Offering to Advance Quebec Mining ProjectNovember 14, 2025 | tipranks.comTroilus Closes $172.5 Million Bought Deal Public Offering Including the Full Exercise of Over-Allotment OptionNovember 14, 2025 | financialpost.comFTroilus Announces $150 Million Bought Deal Public OfferingNovember 7, 2025 | finance.yahoo.comQMEA crowns Troilus Gold industry trailblazer, recognizing copper-gold achievementsOctober 30, 2025 | canadianminingjournal.comCTroilus Wins “Entrepreneur of the Year” Award From the Québec Mineral Exploration Association, Recognizing Leadership in Advancing One of Canada’s Largest Copper-Gold ProjectsOctober 30, 2025 | financialpost.comFTroilus Gold Corp. Changes Auditor to Deloitte LLPOctober 22, 2025 | msn.comGold Breaches $4,200 as Central Banks Buy 3,200 Tonnes Creating Mining WindfallOctober 16, 2025 | baystreet.caTroilus Gold Corp. Advances Towards Construction Readiness with Engineering MilestoneOctober 16, 2025 | msn.comMedia Sentiment Over Time Top HeadlinesView All HeadlinesSpaceX Gets the Attention, But These 4 Stocks Could Get the ReturnsBy Bridget Bennett | May 25, 20265 Stocks Winning the AI Race While Everyone Watches NVIDIABy Bridget Bennett | May 26, 2026Marvell’s Pullback May Be the Setup Bulls Were Waiting ForBy Thomas Hughes | May 29, 2026Marvell’s AI Moment Raises a Bigger Question for Amazon and ServiceNowBy Thomas Hughes | June 3, 2026Semtech’s Explosive Rally May Only Be Getting StartedBy Thomas Hughes | May 28, 2026TLG, BOLT, and CZX Company DescriptionsBolt Biotherapeutics NASDAQ:BOLT$3.99 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$4.16 +0.17 (+4.26%) As of 06/18/2026 06:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.Canada Zinc Metals CVE:CZXC$0.31 +0.31 (+∞) As of 05/4/2018Canada Zinc Metals Corp. explores for and evaluates mineral resource properties in Canada. The company primarily explores for zinc-lead-silver base metals deposits. Its flagship property is the Akie property that consists of 46 mineral claims, which cover approximately 116 square kilometers, located in the Paleozoic Selwyn Basin, British Columbia. The company was formerly known as Mantle Resources Inc. and changed its name to Canada Zinc Metals Corp. in September 2008. Canada Zinc Metals Corp. was incorporated in 1988 and is headquartered in Vancouver, Canada.Troilus Gold CVE:TLGC$0.83 +0.13 (+18.57%) As of 10/19/2018Troilus Gold Corp., a development-stage mineral exploration company, explores for and develops mineral properties in Canada. The company primarily explores for gold and copper deposits. It owns 100% interest in the Troilus project covering an area of 4,718.6 ha located to the northwest of the Val-d'Or district in Quebec. Troilus Gold Corp. is headquartered in Toronto, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/15 - 06/19 Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself? Why Kroger’s Pullback Could Be a Gift for Patient Investors Credo Technologies Accelerates AI—Its Stock Price Will Follow Why Rocket Lab’s Nasdaq-100 Moment Could Change the Story Why Palantir’s Google Cloud Deal Could Change the Debate VMware: Broadcom's Second Biggest Business Set to Accelerate Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
